Design, synthesis and evaluation of novel 5,6,7-trimethoxyflavone-6-chlorotacrine hybrids as potential multifunctional agents for the treatment of Alzheimer's disease.
暂无分享,去创建一个
Jinsong Liu | Sheng-Bing Huang | Jianfeng Ma | H. Deng | Siqian Wang | Shixian Liao | Dafeng Zhang | Zhennan Deng | Jingyuan Yang | Baodi Yin | T. Zheng | Guo-hui Gao
[1] C. To,et al. Potential therapeutic effects of baicalein, baicalin, and wogonin in ocular disorders. , 2014, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[2] F. J. Luque,et al. Tetrahydrobenzo[h][1,6]naphthyridine-6-chlorotacrine hybrids as a new family of anti-Alzheimer agents targeting β-amyloid, tau, and cholinesterase pathologies. , 2014, European journal of medicinal chemistry.
[3] Y. Ohizumi,et al. Anti-dementia Activity of Nobiletin, a Citrus Flavonoid: A Review of Animal Studies , 2014, Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology.
[4] Ying Guo,et al. Design, synthesis, and biological evaluation of (e)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides as novel multifunctional neuroprotective agents. , 2014, Journal of medicinal chemistry.
[5] Sanghyun Lee,et al. Rational design of a structural framework with potential use to develop chemical reagents that target and modulate multiple facets of Alzheimer's disease. , 2014, Journal of the American Chemical Society.
[6] Neng Jiang,et al. Design, synthesis and evaluation of novel tacrine-rhein hybrids as multifunctional agents for the treatment of Alzheimer's disease. , 2014, Organic & biomolecular chemistry.
[7] Xingshu Li,et al. Novel tacrine-ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity. , 2013, Bioorganic & medicinal chemistry letters.
[8] Sai-Sai Xie,et al. Multifunctional tacrine-flavonoid hybrids with cholinergic, β-amyloid-reducing, and metal chelating properties for the treatment of Alzheimer's disease. , 2013, European journal of medicinal chemistry.
[9] Rangappa S. Keri,et al. Design, synthesis and neuroprotective evaluation of novel tacrine-benzothiazole hybrids as multi-targeted compounds against Alzheimer's disease. , 2013, Bioorganic & medicinal chemistry.
[10] Hai-bin Luo,et al. Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer's disease. , 2013, Journal of medicinal chemistry.
[11] S. Garneau‐Tsodikova,et al. Investigation of the role of linker moieties in bifunctional tacrine hybrids. , 2013, Bioorganic & medicinal chemistry.
[12] Xiaobing Wang,et al. Design, synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer's disease. , 2013, Bioorganic & medicinal chemistry letters.
[13] W. Thies,et al. 2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.
[14] I. Ginsburg,et al. Carbamate derivatives of indolines as cholinesterase inhibitors and antioxidants for the treatment of Alzheimer's disease. , 2012, Journal of medicinal chemistry.
[15] Paul Edison,et al. Drug repositioning for Alzheimer's disease , 2012, Nature Reviews Drug Discovery.
[16] Xingshu Li,et al. Multitarget-directed benzylideneindanone derivatives: anti-β-amyloid (Aβ) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer's disease. , 2012, Journal of medicinal chemistry.
[17] Shu Liu,et al. Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease. , 2012, Bioorganic & medicinal chemistry letters.
[18] Filippo Caraci,et al. New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs. , 2012, British journal of clinical pharmacology.
[19] Jörg Rademann,et al. New tacrine-4-oxo-4H-chromene hybrids as multifunctional agents for the treatment of Alzheimer's disease, with cholinergic, antioxidant, and β-amyloid-reducing properties. , 2012, Journal of medicinal chemistry.
[20] Z. Zuo,et al. Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones. , 2011, Biopharmaceutics & drug disposition.
[21] Ding Li,et al. Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as dual inhibitors for cholinesterases and amyloid beta aggregation. , 2011, Bioorganic & medicinal chemistry.
[22] F. J. Luque,et al. Pyrano[3,2-c]quinoline-6-chlorotacrine hybrids as a novel family of acetylcholinesterase- and beta-amyloid-directed anti-Alzheimer compounds. , 2009, Journal of medicinal chemistry.
[23] Richard Morphy,et al. Designing multiple ligands - medicinal chemistry strategies and challenges. , 2009, Current pharmaceutical design.
[24] G. Perry,et al. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. , 2008, CNS & neurological disorders drug targets.
[25] H. Otsuka,et al. Antiviral activity of 5,6,7-trimethoxyflavone and its potentiation of the antiherpes activity of acyclovir. , 1997, The Journal of antimicrobial chemotherapy.